US2021030792A1PendingUtilityA1

Composition for Promoting Increase in Subcutaneous Tissue and Subcutaneous Adipose Tissue

Assignee: YAMAKAWA KENSUKEPriority: Feb 24, 2012Filed: Oct 21, 2020Published: Feb 4, 2021
Est. expiryFeb 24, 2032(~5.6 yrs left)· nominal 20-yr term from priority
A61L 27/54A61L 2430/34A61K 35/16A61K 38/1825A61L 27/3616A61K 9/107A61K 31/22A61L 27/227A61K 9/0041A61L 2300/414A61P 17/00A61K 38/22
50
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

In particular, a composition for breast augmentation that includes a composition promoting an increase in subcutaneous tissue, wherein the promoting composition aims at accumulating and increasing adipose tissue under the skin of a breast by generating and increasing the adipose tissue around a mammary gland and enables recovery of autologous tissue and recovery of appearance by a safe and natural process, and a method for breast augmentation are provided. A composition promoting an increase in subcutaneous tissue that contains autologous plasma and a basic fibroblast growth factor (b-FGF), in particular, a composition for breast augmentation is provided. A composition for breast augmentation that includes the above-described composition promoting an increase in subcutaneous tissue that further contains fat is provided. Specifically, a composition for breast augmentation that includes the above-described composition promoting an increase in subcutaneous tissue, wherein the fat is in the form of a lipid emulsion and the lipid emulsion is an oil-in-water lipid emulsion produced by emulsifying fat and oil in the presence of an emulsifier, and a method for breast augmentation by using the composition are provided. An injection unit of the composition for breast augmentation is also provided.

Claims

exact text as granted — not AI-modified
1 . A composition for promoting an increase in subcutaneous tissue, comprising autologous plasma and a basic fibroblast growth factor (b-FGF). 
     
     
         2 . The composition for promoting an increase in subcutaneous tissue according to  claim 1 , wherein the subcutaneous tissue is subcutaneous cell tissue and/or subcutaneous adipose tissue. 
     
     
         3 . The composition for promoting an increase in subcutaneous tissue according to  claim 1 , further comprising fat. 
     
     
         4 . The composition for promoting an increase in subcutaneous tissue according to  claim 3 , wherein the fat is in a form of a lipid emulsion. 
     
     
         5 . The composition for promoting an increase in subcutaneous tissue according to  claim 4 , wherein the lipid emulsion is an oil-in-water lipid emulsion produced by emulsifying fat and oil in the presence of an emulsifier. 
     
     
         6 . A composition for breast augmentation, comprising the composition for promoting an increase in subcutaneous tissue according to  claim 1 , used for breast augmentation. 
     
     
         7 . An injection unit for breast augmentation, comprising a composition for breast augmentation containing autologous plasma and a basic fibroblast growth factor (b-FGF). 
     
     
         8 . The injection unit according to  claim 7 , further comprising fat. 
     
     
         9 . The injection unit according to  claim 8 , wherein the fat is in a form of a lipid emulsion. 
     
     
         10 . The injection unit according to  claim 9 , wherein the lipid emulsion is an oil-in-water lipid emulsion produced by emulsifying fat and oil in the presence of an emulsifier.

Join the waitlist — get patent alerts

Track US2021030792A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.